Piramal Critical Care

Company snapshot

Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is a leader in inhaled anesthetics and a global player in hospital generics. “Saving and improving patients’ lives” is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers, while achieving sustainable and prof

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Piramal Critical Care. Not investment advice.

• What is Piramal Critical Care?

  Piramal Critical Care is a pharma organization headquartered in Voorschoten, NL. Primary therapeutic focus areas include Melanoma. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and US

• Is Piramal Critical Care publicly traded?

  Piramal Critical Care appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Piramal Critical Care develop or market?

  We link 1 drug profile(s) where Piramal Critical Care is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/piramal-critical-care-b-v#company-drugs.

• What are the latest developments for Piramal Critical Care?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Piramal Critical Care focus on?

  Piramal Critical Care focuses on Melanoma based on our analysis of their pipeline programs and drug development activities.